Cholesterol Depletion Upregulates Involucrin Expression in Epidermal Keratinocytes Through Activation of p38  by Jans, Ralph et al.
Cholesterol Depletion Upregulates Involucrin Expression in
Epidermal Keratinocytes Through Activation of p38
Ralph Jans, Ganka Atanasova,w Michel Jadot,z and Yves Poumay
De´partement Histologie-Embryologie, Faculte´s Universitaires Notre-Dame de la Paix, Namur, Belgium; wDepartment of Biochemistry, University of Sofia,
Sofia, Bulgaria; zUnite´ de Recherche en Physiologie Mole´culaire, Laboratoire de Chimie Physiologique, Faculte´s Universitaires Notre-Dame de la Paix,
Namur, Belgium
Cholesterol has been recently suggested to regulate the early steps of keratinocyte differentiation through lipid
rafts. In many cell types, depletion of cholesterol activates signaling proteins like epidermal growth factor receptor
(EGFR), human epidermal growth factor receptor 2 (HER2), or extracellular signal-regulated kinase (ERK) known to
affect cell differentiation. In this study, we explored the effects of cholesterol depletion on the phenotype of
cultured keratinocytes, using a treatment with methyl-b-cyclodextrin (MbCD) to extract cholesterol and a treatment
with lovastatin to inhibit cholesterol neosynthesis. Analysis of the expression of differentiation marker genes in
early differentiating conﬂuent cultures reveals that cholesterol depletion induces downregulation of keratin 14
(K14) and keratin 10 (K10) and upregulation of involucrin. MbCD treatment induces phosphorylation of EGFR,
HER2, and ERK, but not HER3. Inhibition of EGFR with PD153035 impairs the MbCD-induced phosphorylation of
EGFR, HER2, and ERK, but does not impair the alteration of K14, K10, or involucrin gene expression, indicating
that other signaling proteins regulate this phenomenon. p38 has been suggested to regulate the expression of
involucrin during keratinocyte differentiation. We found that MbCD treatment induces a prolonged phosphorylation
of p38 in general and p38a in particular. An inhibition of p38 with PD169316 impairs the upregulation of involucrin
mRNAs by a treatment with MbCD, but not by a p38d-activating TPA treatment, which might suggest that cholesterol
depletion alters involucrin gene expression through activation of p38a/b.
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The epidermis is a stratified squamous epithelium mainly
composed of keratinocytes. In the basal epidermal layer
that is anchored to the basement membrane, slowly
clonogenic stem keratinocytes produce rapidly replicating
transit-amplifying cells that migrate outwardly from the
basal layer in the spinous, granular, and cornified layers
while undergoing a complex differentiation program. The
evolution from a basal keratinocyte to a differentiated
corneocyte is associated with a tight regulation of the
expression of differentiation-related proteins. For example,
expression of the basal keratins 5 and 14 (K5, K14) is
repressed upon entry of the cells into the spinous layer,
where expression of the suprabasal keratins 1 and 10 (K1,
K10) is induced, whereas the differentiation marker involu-
crin appears in the upper spinous and granular layers
(Fuchs, 1990).
The mechanisms that guarantee epidermal homeostasis
by regulating keratinocyte proliferation, migration, and
differentiation have been elucidated in part. Cell-adhesion
proteins (e.g., integrins, cadherins), membrane receptors
(e.g., HER) and their ligands (e.g., epidermal growth factor
(EGF), heregulins), associated intracellular signaling pro-
teins (e.g., protein kinase C, mitogen-activated protein
kinase (MAPK)), and calcium ions all intervene in the
regulation of keratinocyte physiology (Eckert et al, 1997;
Watt, 2002).
Lipids are also involved in epidermal differentiation. For
example, cholesterol is synthesized in epidermal keratino-
cytes (Ponec et al, 1985), and cholesterol transport occurs
in differentiating keratinocytes via specific ATP-binding
cassette (ABC) transporters (Kielar et al, 2003). Cholesterol
has been shown to be involved in the late stages of
epidermal differentiation by promoting cornified envelope
formation (Schmidt et al, 1991) or by being a critical
constituent of the epidermal lipid barrier (Menon et al,
1992). Cholesterol is enriched together with sphingolipids in
discrete membrane microdomains named lipid rafts. Sev-
eral signaling proteins share an affinity for lipid rafts and
their localization within lipid rafts influences their signaling
properties (Simons and Toomre, 2000), such as the
epidermal growth factor receptor (EGFR) (Ringerike et al,
2002; Roepstorff et al, 2002), or the human epidermal
growth factor receptor 2 (HER2) (Nagy et al, 2002). The
presence of lipid rafts at the plasma membrane of
keratinocytes has been described (Gniadecki et al, 2002).
Very recently, an enrichment of lipid rafts has been identified
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in transit amplifying keratinocytes compared with stem
cells, suggesting an involvement of lipid rafts in regulating
the keratinocyte phenotype (Gniadecki and Bang, 2003).
Thus, the literature provides many observations that
suggest important roles of cholesterol and lipid rafts in the
physiology of epidermal keratinocytes.
Physiological roles of plasma membrane cholesterol can
be investigated by observing the effects of a depletion of
cholesterol. This can be accomplished by incubating
cultured cells with methyl-b-cyclodextrin (MbCD), a cyclic
polysaccharide that extracts cholesterol from cellular
membranes (Klein et al, 1995) and thereby disrupts lipid
rafts (Kabouridis et al, 2000). In several cell types,
cholesterol depletion by MbCD has been found to induce
phosphorylation of the EGFR and to influence the activity of
HER2 (Chen and Resh, 2002; Nagy et al, 2002; Pike and
Casey, 2002). The physiology of epidermal keratinocytes,
however, is modulated by the activity of EGFR (Piepkorn
et al, 1998; Jost et al, 2000) and HER2 (De Potter et al, 2001;
Stoll et al, 2001), which act as receptor tyrosine kinases and
mediate several signaling pathways (Schlessinger, 2000;
Yarden and Sliwkowski, 2001). Associating with HER2, a
third member of the HER family named HER3 has been
proposed to play roles in epidermal differentiation (De
Potter et al, 2001).
Acting through the EGFR, cholesterol depletion has been
suggested to activate MAPK effector proteins, namely, the
extracellular signal-regulated kinases (ERK) 1 and 2 (Furuchi
and Anderson, 1998; Kabouridis et al, 2000; Chen and
Resh, 2001). Other MAP kinases beside ERK are the p38
kinases, which play a major role in the cellular response to
environmental and physiological stresses (Kyriakis and
Avruch, 2001). p38 activity can be modulated by a depletion
of cholesterol (Hossain et al, 2000; Iwabuchi and Nagaoka,
2002). Involvement of MAP kinases in regulating epidermal
differentiation has been suggested: keratinocyte prolifera-
tion and survival would be influenced by ERK1/2, whereas
keratinocyte differentiation and apoptosis would rather be
influenced by p38 (Eckert et al, 2002). The p38 MAPK family
includes the p38a, p38b, p38g, and p38d isoforms, but only
the a, b, and d isoforms are expressed in keratinocytes
(Dashti et al, 2001). In these cells, involucrin expression can
be regulated by both p38a and p38d (Dashti et al, 2001;
Efimova et al, 2002; Efimova et al, 2003).
In this study, we investigated the effects of cholesterol
depletion on the differentiation of epidermal keratinocytes.
We explored the effects of cholesterol depletion on signal
transduction within keratinocytes, focusing on the activation
state of receptors (EGFR, HER2, and HER3) and MAP
kinase effectors (ERK, p38) relevant in keratinocyte differ-
entiation.
Results
Treatment with MbCD induces extraction of cholesterol
from keratinocytes In order to analyze the effects of a
treatment with MbCD on the concentration of cholesterol
within keratinocytes, keratinocyte cultures were subjected
to a treatment with 7.5 mM MbCD for 1 h and cell lysates
were assayed for cholesterol and protein concentrations. As
shown in Fig 1A, MbCD treatment induces a weak but
significant (po0.01) decrease in the concentration of
cholesterol in keratinocytes (n¼7).
In order to analyze the localization of cholesterol in
keratinocytes following treatment with MbCD, cells grown
on glass plates were labeled using filipin. Untreated
keratinocytes exhibit plasma membrane staining of filipin
(Fig 1B, a). Treatment with 7.5 mM MbCD for 1 h
dramatically reduced the labeling of the plasma membrane
(Fig 1B, b), suggesting extraction of plasma membrane
cholesterol by MbCD (Klein et al, 1995). Conversely to
untreated keratinocytes, intracellular perinuclear filipin
labeling is visible after treatment with MbCD. MbCD
Figure 1
MbCD treatment extracts plasmamem-
brane cholesterol from keratinocytes.
(A) Keratinocyte cultures were treated for
1 h with 7.5 mM MbCD and assayed for
their cholesterol and protein content.
Results are expressed as nmol of choles-
terol per mg of protein. The data (n¼ 7)
were compared using the unpaired Stu-
dent t test (n¼7, po0.01). (B) Filipin
labeling was performed on keratinocyte
cultures, which were either left untreated
(a) or treated for 1 h with 7.5 mM MbCD
(b) or MbCD complexed with cholesterol
(c). Observation was performed using a
microscope equipped for epifluorescence
and pictures were taken using identical
exposition times for all analyzed samples
(bar¼20 mm).
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molecules can be complexed with cholesterol prior to
incubation with cultured cells, resulting in a suppressed
cholesterol-extracting ability of MbCD (Klein et al, 1995).
Several authors have used cholesterol-complexed MbCD
as a control in experiments involving cholesterol extraction
from cells by MbCD (Kabouridis et al, 2000). Treatment of
keratinocytes with MbCD complexed with cholesterol does
not alter the filipin staining of the plasma membrane (Fig 1B,
c), which remains similar to untreated cells. This observation
confirms that cholesterol-complexed MbCD does not
extract cholesterol from the plasma membrane of keratino-
cytes.
Chronic cholesterol depletion of keratinocytes results in
an altered gene expression of K14, K10, and involucrin
Next, we sought to know whether cholesterol depletion
affects the differentiation process of keratinocytes. We
analyzed the mRNA expression of the basal keratin 14
(K14), of the suprabasal keratin 10 (K10), and of involucrin,
which is a marker of epidermal differentiation because it is
mainly expressed in the upper spinous and granular layers.
In autocrine culture conditions, differentiation markers
exhibit a characteristic expression pattern dependent on
cell density (Poumay and Pittelkow, 1995; Poumay et al,
1999). Subconfluent, confluent, and postconfluent kerati-
nocyte cultures were subjected to the following treatments.
A transient cholesterol depletion was performed by incu-
bating keratinocyte cultures with 7.5 mM MbCD for 1 h
followed by an incubation for 17 h in culture medium. A
chronic depletion of cholesterol was induced by incubating
cultures with 7.5 mM MbCD for 1 h followed by inhibition of
cholesterol biosynthesis by treatment with 10 mM lovastatin
for 17 h.
In untreated keratinocyte cultures, K14 gene expression
is observed in subconfluent, confluent, and postconfluent
cultures. K10 gene expression is induced in confluent and
postconfluent cultures and involucrin gene expression is
strongly upregulated in postconfluent cultures (Fig 2A). In
confluent cells, a combined treatment with MbCD and
lovastatin induces an obvious downregulation of K14 and
K10 mRNA and a strong upregulation of involucrin mRNA.
Treatment of confluent keratinocytes with MbCD results in a
minor upregulation of the amount of involucrin mRNA,
whereas lovastatin treatment does not induce any detect-
able modification of the mRNA expression patterns. These
results show that the phenotype of keratinocytes in
confluent cultures is obviously altered upon cholesterol
depletion.
In order to explore whether the alteration of the
keratinocyte phenotype at confluence is correlated to
the cholesterol-extracting ability of MbCD, we analyzed
the effects of a treatment with MbCD complexed with
cholesterol and a treatment with lovastatin. This treatment
does not result in altered K14, K10, or involucrin mRNA
expression (Fig 2B). A similar result was observed when
keratinocyte cultures were subjected to a treatment with
MbCD, a subsequent treatment with cholesterol-complexed
MbCD and a treatment with lovastatin. a-Cyclodextrin is
less efficient that b-cyclodextrins in extracting membrane
cholesterol (Ohtani et al, 1989; Nakanishi et al, 1992) and a
treatment of keratinocytes with a-cyclodextrin and lovasta-
tin does not result in an altered expression of K14, K10, or
involucrin (data not shown). These results strongly suggest
that the alteration of the keratinocyte phenotype is a
consequence of cholesterol depletion.
Since the effects of MbCD have been linked to the
treatment duration (Park et al, 1998; Lai, 2003), we analyzed
the gene expression of K14, K10, and involucrin in confluent
keratinocyte cultures subjected to a treatment with MbCD
for 15, 30, or 60 min and a treatment with lovastatin for 17 h.
Figure 2
Cholesterol depletion induces downregulation of keratin 14 and keratin 10 mRNA expression and upregulation of involucrin mRNA
expression in confluent keratinocyte cultures. (A) Experiments were performed on subconfluent, confluent, and postconfluent keratinocyte
cultures in autocrine growth conditions. Keratinocyte cultures were subjected to a control incubation with autocrine growth medium for 18 h.
Transient cellular cholesterol depletion was achieved by treatment with 7.5 mM MbCD for 1 h followed by incubation for 17 h in culture medium.
Chronic depletion of cellular cholesterol was performed by a transient treatment with 7.5 mM MbCD for 1 h followed by inhibition of cholesterol
biosynthesis by treatment with 10 mM lovastatin for 17 h. Inhibition of cholesterol neosynthesis without initial cholesterol depletion was
accomplished by treatment with 10 mM lovastatin for 17 h. Upon completion of the experiments, keratinocyte cultures were subjected to poly-A RNA
extraction. Samples were analyzed by northern blotting using serial hybridizations of the membrane with cDNA probes specific for keratin 14 (K14),
keratin 10 (K10), and involucrin followed by autoradiography. Gel loading was analyzed by hybridization of the membrane with a cDNA probe
specific for the reference gene 36B4. (B) Confluent keratinocyte cultures were treated with MbCD or cholesterol-complexed MbCD for 1 h and were
then incubated with lovastatin for 17 h. Other cultures were incubated with MbCD for 1 h, with cholesterol-complexed MbCD for 1 h and with
lovastatin for 16 h. Samples were analyzed for expression of K14, K10, and involucrin mRNA as described above. Shown is a representative result of
two experiments performed on different keratinocyte strains. (C) Confluent keratinocyte cultures were treated with MbCD for 15, 30, or 60 min and
with lovastatin for 17 h. Samples were analyzed for expression of K14, K10, and involucrin mRNA as described above.
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As shown in Fig 2C, the effects of a treatment with MbCD
and lovastatin on the gene expression of K14, K10, and
involucrin are time dependent.
Cholesterol depletion induces autophosphorylation of
EGFR but does not affect ERK phosphorylation, and
does not alter the gene expression of K14, K10, and
involucrin through activation of EGFR We hypothesized
that a treatment with MbCD and lovastatin could induce the
activation of signal transduction cascades, which regulate
the expression of K14, K10, and involucrin. One candidate
pathway involves the EGFR. Indeed, activation of the EGFR
by a treatment of keratinocytes with EGF is known to
downregulate the expression of K10 (Poumay and Pittelk-
ow, 1995). We verified in confluent cultures that EGF
treatment downregulates K10 mRNA (Fig 3A). EGF treat-
ment of reconstructed epidermis is known to induce a
precocious expression of involucrin in the spinous layer
(Gibbs et al, 1998; Gibbs et al, 2000). We found that EGF
treatment of confluent keratinocyte cultures upregulates
involucrin mRNA (Fig 3A). MbCD treatment could thus alter
the gene expression of K10 and involucrin through the
activation of EGFR.
To investigate this hypothesis, we analyzed the phos-
phorylation state of EGFR following a treatment with MbCD.
As shown in Fig 3B, untreated confluent keratinocyte
cultures exhibit undetectable basal amounts of phosphory-
lated EGFR, whereas a treatment with 7.5 mM MbCD for 1 h
obviously induces EGFR phosphorylation. Analysis of the
effect of a treatment with cholesterol-charged MbCD
reveals no rise in EGFR phosphorylation under these
conditions (Fig 3B).
PD153035 is a compound that specifically inhibits EGFR
tyrosine kinase activity at nanomolar concentrations (Fry
et al, 1994). Pre-treatment of keratinocytes with PD153035
followed by treatment with MbCD results in a level of EGFR
phosphorylation similar to the level in untreated cells (Fig
3C). The MbCD-induced activation of EGFR probably
results from autophosphorylation since this activation is
largely dependent on the tyrosine kinase activity of
EGFR.
Activation of EGFR can induce activation of the MAPK/
ERK kinase (MEK), which in turn can activate the MAP
kinase ERK (Schlessinger, 2000). As shown in Fig 3B and C,
treatment of keratinocytes with MbCD does not affect ERK
phosphorylation. In untreated confluent keratinocytes, the
levels of phosphorylated ERK are elevated (Fig 3B and C),
which is probably due to stimulation of EGFR by auto- and
paracrine EGFR ligands secreted by these cells in serum-
free culture conditions (Cook et al, 1991; Pittelkow et al,
1993; Iordanov et al, 2002).
To investigate whether cholesterol depletion alters
keratinocyte differentiation through EGFR activation, con-
fluent keratinocyte cultures were incubated with 500 nM
PD153035 for 30 min before treatment with MbCD and
lovastatin. As shown in Fig 3D, inhibition of EGFR tyrosine
kinase activity does not impair the alteration of the
expression of K14, K10, and involucrin induced by
cholesterol depletion, suggesting that another signaling
pathway is responsible for this alteration of the keratinocyte
phenotype.
Figure3
Cholesterol depletion induces autophosphorylation of EGFR but
not ERK, and does not alter the gene expression of K14, K10 or
involucrin through activation of EGFR. (A) Confluent keratinocyte
cultures were either left untreated or treated with 10 ng/mL EGF for
18 h. Following poly-A RNA extraction, samples were analyzed by
northern blotting as described in Fig 2. (B) Keratinocyte cultures were
treated with 7.5 mM MbCD or with cholesterol-complexed MbCD for
1 h. Other cultures were treated with 10 ng/mL EGF for 10 min. Cellular
lysates were prepared and analyzed by western blotting using
antibodies specific for the phosphorylated forms of EGFR and
phosphorylated ERK. Gel loading was analyzed by immunodetection
of total ERK and of a-tubulin and by amidoblack staining of the blotted
membrane (not shown). This experiment was repeated twice using
different keratinocyte strains with similar results. (C) Keratinocyte
cultures were treated with 7.5 mM MbCD for 1 h, with 500 nM
PD153035 for 90 min or with 10 ng/mL EGF for 10 min. Other cultures
were treated with 500 nM PD153035 for 30 min, then with PD153035
and MbCD for 1 h or with PD153035 and EGF for 10 min. Following
treatments, cellular lysates were prepared and analyzed for phos-
phorylated EGFR and phosphorylated ERK as described for panel B.
The experiment was repeated three times using different keratinocyte
strains with similar results. (D) Keratinocyte cultures were treated with
MbCD for 1 h and lovastatin for 17 h, or with 500 nM PD153035 for 18
h, or with MbCD, lovastatin, and PD153035. Following poly-A RNA
extraction, samples were analyzed by northern blotting as described in
Fig 2.
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Cholesterol depletion induces EGFR-dependent phos-
phorylation of HER2, but does not affect the phosphor-
ylation state of HER3 Beside the EGFR, keratinocytes also
express HER2 and HER3, which have been suggested to be
involved in the regulation of keratinocyte differentiation (De
Potter et al, 2001; Stoll et al, 2001; Piepkorn et al, 2003). For
instance, heregulin treatment of keratinocytes induces
heterodimerization of HER3 with HER2 and transphosphor-
ylation of HER3 by HER2, leading to downregulation of the
expression of K10 (De Potter et al, 2001). Analysis of the
tyrosine phosphorylation of HER3 reveals that MbCD
treatment does not induce HER3 phosphorylation above
the basal level, though its ligand HRGb increases phos-
phorylation (Fig 4A). On the other hand, analysis of the
tyrosine phosphorylation of HER2 shows that it is barely
detectable in untreated keratinocytes, but increased follow-
ing MbCD treatment (Fig 4B).
Treatment with MbCD could induce phosphorylation of
HER2 through EGFR activation. To explore this hypothesis,
EGFR tyrosine kinase was inhibited by PD153035 prior to a
treatment with MbCD, which results in undetectable HER2
phosphorylation (Fig 4C), suggesting that EGFR is respon-
sible for HER2 activation upon MbCD treatment. Since
EGFR-mediated signaling is probably not involved in the
downregulation of K10 expression upon cholesterol deple-
tion (Fig 3D), HER2 is probably neither involved in this
phenomenon.
Cholesterol depletion induces activation of p38 The
MAP kinase p38 is involved in the upregulation of the
expression of involucrin during the late stages of keratino-
cyte differentiation (Efimova et al, 2003). Treatment with
MbCD could result in an upregulation of the expression of
involucrin through activation of p38. Analysis of the
phosphorylation state of p38 shows that a basal level of
phosphorylated p38 is detectable in untreated keratino-
cytes (Fig 5A). MbCD treatment obviously results in an
increased level of phosphorylated p38, but not phosphory-
Figure 4
Cholesterol depletion does not affect HER3 phosphorylation, but
induces EGFR-dependent phosphorylation of HER2. (A) Keratino-
cyte cultures were treated with 7.5 mM MbCD, 10 ng/mL HRGb or
7.5 mM cholesterol-complexed MbCD for 1 h. Cellular lysates were
prepared and analyzed for phosphorylated HER3 by immunoprecipita-
tion of HER3 and western blotting using phosphotyrosine-specific
antibodies. Gel loading was analyzed by immunodetection of total
HER3 after stripping the membrane. The experiment was repeated
twice using different keratinocyte strains with similar results. (B)
Keratinocyte cultures were treated with 7.5 mM MbCD or with
cholesterol-complexed MbCD for 1 h or with 10 ng per mL EGF for
10 min. Cellular lysates were prepared and analyzed by western
blotting using antibodies specific for the phosphorylated form of HER2.
Gel loading was analyzed by immunodetection of total ERK. This
experiment was repeated twice using different keratinocyte strains with
similar results. (C) Keratinocyte cultures were treated with 7.5 mM
MbCD for 1 h, with 500 nM PD153035 for 90 min or with 10 ng per mL
EGF for 10 min. Other cultures were treated with 500 nM PD153035 for
30 min, then with PD153035 and MbCD for 1 h or with PD153035 and
EGF for 10 min. Following treatments, cellular lysates were prepared
and analyzed for phosphorylated HER2 as described for panel B. The
experiment was repeated three times using different keratinocyte
strains with similar results.
Figure5
Cholesterol depletion induces prolonged phosphorylation of p38.
Following treatments of keratinocyte cultures, cellular lysates were
prepared and analyzed by western blotting using antibodies specific for
phosphorylated p38 and phosphorylated ERK in panels A, B, and C.
Gel loading was analyzed by immunodetection of total p38 and total
ERK after membrane stripping. All panels exhibit representative results
out of duplicate experiments performed on different keratinocyte
strains. (A) Keratinocytes were treated with 7.5 mM MbCD or with
cholesterol-complexed MbCD for 1 h or with 10 ng per mL EGF for
10 min. (B) Keratinocytes were treated with MbCD for 1 h, treated with
15 mM PD169316 for 90 min or treated with 15 mM PD169316 for
30 min and with PD169316 and MbCD for 1 h. (C) Keratinocytes were
treated with MbCD, with MbCD and lovastatin or with lovastatin as
described in Fig 2.
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lated ERK. Treatment with EGF also induces some p38
phosphorylation, in accordance with other studies (Cheng
et al, 2002; Huang et al, 2002), while inducing an important
increase in the levels of phosphorylated ERK. Treatment of
keratinocytes with cholesterol-complexed MbCD does not
seem to alter the basal level of p38 phosphorylation. The
kinase activity of p38 is inhibited by the compound
PD169316 (Kummer et al, 1997). We show that the
MbCD-induced upregulation of phosphorylated p38 is
impaired by a treatment with 15 mM PD169316 (Fig 5B),
suggesting that MbCD treatment induces autophosphoryla-
tion of p38.
Next, we explored whether the activation state of p38 is
affected by a treatment with MbCD and lovastatin. As
shown in Fig 5C, analysis of the phosphorylation of p38
exhibits an obvious upregulation of the amount of phos-
phorylated p38 (but not phosphorylated ERK) after a
treatment with MbCD for 1 h and with lovastatin for 17 h.
This observation indicates that cholesterol depletion in-
duces prolonged activation of p38 in keratinocytes.
Cholesterol depletion induces activation of p38a and
alters involucrin expression through p38a/b The p38
isoforms activated by cholesterol depletion were then
identified by detecting phosphorylated p38a, p38b, and
p38d. As shown in Fig 6A, a slightly elevated amount of
phosphorylated p38a could be detected in keratinocytes
following a treatment with MbCD and lovastatin. This
treatment did not seem to affect the amount of phosphory-
lated p38b or p38d compared to untreated cells. Similar to
previously published observations (Efimova et al, 2002), a
treatment with TPA clearly elevated the amount of phos-
phorylated p38d.
To examine whether p38 activation could be involved in
upregulating the involucrin expression upon cholesterol
depletion, p38 tyrosine kinase was inhibited by a treatment
with PD169316 before a MbCD and a lovastatin treatment.
As shown in Fig 6B, PD169316 impairs the upregulation of
involucrin mRNA levels upon cholesterol depletion. This
result strongly suggests that the upregulation of the gene
expression of involucrin upon cholesterol depletion is
induced by p38 activity.
PD169316 belongs to the pyridinyl imidazole family of
p38 inhibitors (Young et al, 1997) and has been suggested
to specifically inhibit p38a and p38b (Eckert et al, 2002;
Hendrickx et al, 2003). As mentioned above, the MbCD/
lovastatin-induced involucrin expression is inhibited by
PD169316 (Fig 6B), indicating that p38a and/or p38b are
involved in this phenomenon. Although it remains to be
determined whether PD169316 inhibits p38d, it is known
that the pyridinyl imidazole compound SB203580 inhibits
p38a and p38b, but not p38d (Cohen, 2002). Treatment of
keratinocytes with TPA induces expression of involucrin,
which is not inhibited by SB203580 (Efimova et al, 1998;
Eckert et al, 2002; Efimova et al, 2002), suggesting along
with other evidence (Efimova et al, 2002; Efimova et al,
2003) that this phenomenon does not depend on p38a or
p38b but on p38d. Our results show that the TPA-induced
expression of involucrin is also insensitive to PD169316 (Fig
6C), indicating that this compound does not inhibit p38d.
Since MbCD/lovastatin-induced involucrin expression is
inhibited by PD169316, MbCD/lovastatin treatment prob-
ably alters involucrin expression through activation of p38a
or p38b, but not p38d.
Discussion
To gain insight into the role of cholesterol in keratinocyte
differentiation, we investigated the effects of cholesterol
depletion on this process. We demonstrate that cultured
keratinocytes incubated with MbCD are depleted of plasma
membrane cholesterol, as shown by a diminished concen-
tration of cellular cholesterol and a less intense filipin
staining of the plasma membrane. MbCD treatment of
keratinocytes also results in intracellular filipin staining.
Since filipin exhibits a relatively low molecular weight (654.8
g per mol), and since MbCD treatment could have disturbed
the permeability of the plasma membrane, intracellular
cholesterol could have become accessible to filipin. Entry of
MbCD into keratinocytes is unlikely since MbCD does not
bind nor insert into the plasma membrane in erythrocytes
(Ohtani et al, 1989). The intracellular localization of filipin
observed upon MbCD treatment exhibits a perinuclear
pattern, reminding the results described by McGookey who
attributes a similar pattern to the localization of lysosomal
cholesterol (McGookey et al, 1983).
Keratinocyte differentiation is a consequence of a tight
regulation of gene expression (Fuchs, 1990). This work
Figure 6
Cholesterol depletion induces phosphorylation of p38a. Inhibition
of p38 impairs the upregulation of the gene expression of
involucrin induced upon cholesterol depletion. (A) Keratinocytes
were treated with MbCD and lovastatin as described in Fig 2 or with
10 ng per mL TPA for 18 h. Following treatments, cellular lysates were
prepared and analyzed by immunoprecipitation using antibodies
specific for p38a, p38b, and p38d and by western blotting using
antibodies specific for phosphorylated p38. Gel loading was analyzed
by immunodetection of p38a, p38b, and p38d. This experiment was
repeated twice with similar results. (B) Keratinocyte cultures were
treated with MbCD for 1 h and lovastatin for 17 h, with 15 mM PD169316
for 18 h, or with MbCD, lovastatin, and PD169316. Following poly-A
RNA extraction, samples were analyzed by northern blotting as
described in Fig 2. This experiment was repeated twice using different
keratinocyte strains with similar results.
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shows for the first time that cholesterol depletion can alter
the expression of certain genes involved in keratinocyte
differentiation.
Activation of the EGFR by EGF is known to affect the
expression of genes in keratinocytes (Poumay and Pittelkow,
1995) whose expression is also altered upon cholesterol
depletion. We found indeed that MbCD treatment of kerati-
nocytes induces tyrosine phosphorylation of EGFR. Phos-
phorylation of EGFR by MbCD has been observed in 3T3 or
COS-1 cells (Chen and Resh, 2002; Pike and Casey, 2002).
We wondered whether MbCD treatment alters gene expres-
sion in keratinocytes through this receptor, but inhibition of
EGFR tyrosine kinase activity does not prevent this alteration,
suggesting that EGFR-induced pathways are not involved.
We turned our attention to other signaling proteins, which
might be involved in regulating gene expression upon
MbCD treatment of keratinocytes. The p38 MAP kinases
are involved for instance in the upregulation of involucrin
expression in keratinocytes, particularly p38a and p38d
(Dashti et al, 2001; Efimova et al, 2002; Efimova et al, 2003).
We found that treatment of epidermal keratinocytes with
MbCD results in phosphorylation of p38. Furthermore, we
demonstrate that inhibition of p38 kinase activity impairs the
upregulation of involucrin upon MbCD treatment, suggest-
ing that involucrin gene expression is upregulated through
p38 activation.
We also found that p38a seems to be activated upon
MbCD treatment. Furthermore, we observed that (conver-
sely to the TPA-induced upregulation of the involucrin
expression) the MbCD-induced upregulation of the involu-
crin expression is inhibited by PD169316. TPA-induced
involucrin expression, however, is p38d-dependent (Efimo-
va et al, 2002; Efimova et al, 2003), suggesting that
cholesterol depletion does not alter involucrin expression
through p38d. This response could proceed through p38a
since this p38 isoform seems activated upon cholesterol
depletion (Fig 6A) and is inhibited by PD169316 (Hendrickx
et al, 2003).
In keratinocytes, p38a and/or p38b are involved in the
response to treatments like UVB irradiation, oxidative
stress, tumor necrosis factor a, interleukin 1b (Zhang et al,
2001) or osmotic stress (Garmyn et al, 2001), thus mediating
cell stress responses (Eckert et al, 2002). The p38a-
dependent alteration of the keratinocyte phenotype by
cholesterol depletion that we describe in this study could
thus be part of a cell stress response induced by this
treatment.
At this moment, we do not have any evidence regarding
the possible mechanism(s) by which MbCD treatment can
induce phosphorylation of p38 in keratinocytes. p38 can be
phosphorylated in keratinocytes by Rho GTPases (Cheng
et al, 2002). In fibroblasts, apolipoprotein A-I-induced
cholesterol efflux from the plasma membrane activates
Rho GTPases and activates p38 downstream of these
GTPases (Nofer et al, 2003). In keratinocytes, MbCD-
mediated cholesterol extraction from the plasma membrane
could possibly activate p38 through activation of Rho
GTPases.
Cholesterol is known to be involved in keratinocyte
physiology by promoting cornified envelope formation
(Schmidt et al, 1991) or by being a critical constituent of
the epidermal lipid barrier (Menon et al, 1992), thus playing
important roles in differentiation. The results presented in
this study point to an as yet undescribed involvement of
cholesterol in this process since depletion of cholesterol
alters the expression of the epidermal differentiation
markers K14, K10, and involucrin. Downregulation of K10
and upregulation of involucrin has been interpreted as
changes in keratinocyte gene expression that occur during
the spinous to granular cell transition in the epidermis
(Dlugosz and Yuspa, 1993). Cholesterol depletion induces
similar changes in the expression of these genes, which
might suggest that cholesterol is involved in regulating this
transition.
When investigating the causes of an epidermal pathol-
ogy, the involvement of a certain molecule is suspected
when this molecule exhibits altered properties in the
pathological state. For example, elevated levels of choles-
terol have been detected in psoriatic patients (Benton et al,
1963), and lipid-lowering drugs can induce exacerbation of
psoriasis (Fisher et al, 1988), suggesting an involvement of
cholesterol in this disease. Psoriatic epidermis exhibits
altered expression of differentiation marker genes: a K14-
specific antibody only stains a small subset of basal
keratinocytes (Parent et al, 1994), psoriatic skin exhibits
diminished K10 expression (van Erp et al, 1989), basal and
several rows of suprabasal cells are devoid of K10 (Bernerd
et al, 1992) and involucrin is precociously expressed and
present in all but basal epidermal layers (Watanabe et al,
1991). Most interestingly, the altered pattern of differentia-
tion gene expression in psoriatic keratinocytes is similar to
cholesterol-depleted keratinocytes, which might suggest
that altered differentiation in psoriasis could be linked to
altered cholesterol levels in keratinocytes.
We show that a treatment with MbCD induces activation
of p38 in keratinocytes. Several studies point to an
involvement of p38 in psoriasis. Psoriatic keratinocytes
exhibit p38-dependent phosphorylation of keratins (Toivola
et al, 2002). p38 is involved in the regulation of the gene
expression of skin-derived antileukoprotease (SKALP)/elafin
(Pol et al, 2003), which is strongly upregulated in psoriatic
keratinocytes (Kuijpers et al, 1997). Our unpublished results
show that MbCD treatment of keratinocytes strongly
upregulates the expression of heparin-binding EGF (HB-
EGF), which is overexpressed in lesional psoriatic skin (Stoll
and Elder, 1998). MbCD-induced HB-EGF expression is
impaired upon inhibition of p38 (our unpublished results).
Clinical trials are ongoing with p38 kinase inhibitors for
treatment of psoriasis (Lee et al, 2000). Thus, a correlation
might exist between altered cholesterol levels, p38, and
psoriasis.
Taken together, our data demonstrate that cholesterol
depletion modulates the phenotype of early differentiating
keratinocytes and the activity of signaling proteins known to
regulate keratinocyte differentiation, suggesting that cho-
lesterol is involved in the regulation of the early steps of
keratinocyte differentiation.
Materials and Methods
Chemicals and antibodies Triton X-100, glycin, paraformalde-
hyde and methanol-stabilized 37% formaldehyde solution, and
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dimethylsulfoxide (DMSO) were obtained from Merck (Darmstadt,
Germany). MbCD, cholesterol, 12-O-tetradecanoyl-phorbol-13-
acetate (TPA), bovine serum albumin (BSA), lovastatin, filipin,
amidoblack solution, sodium deoxycholate, and mouse mono-
clonal anti-a-tubulin antibody were purchased from Sigma-Aldrich
(Bornem, Belgium). Protein A-agarose and protein G-agarose were
obtained from Roche (Basel, Switzerland). Sodium dodecylsulfate
(SDS) and dithiothreitol (DTT) were obtained from Acros (Geel,
Belgium). PD153035 was purchased from A.G. Scientific (San
Diego, California). AG825 and PD169316 were obtained from
Calbiochem (San Diego, California). EGF and heregulin b were
purchased from R&D Systems (Minneapolis, Minnesota).
Mouse monoclonal antibodies against phosphotyrosine and
rabbit polyclonal phosphospecific antibodies against EGFR
(pY1173) and against p38 were obtained from BioSource (Nivelles,
Belgium). Rabbit polyclonal anti-phospho-ErbB2-HER-2 (pY1248)
antibody, anti-ERK1/2 antibody, and mouse monoclonal anti-
phospho-ERK1/2 antibody were obtained from Upstate Biotech-
nology (Lake Placid, New York). Rabbit polyclonal anti-HER3
antibody was purchased from Novocastra (Newcastle-upon-Tyne,
UK). Rabbit polyclonal anti-p38 antibody, goat polyclonal anti-
p38b, and goat polyclonal anti-p38d antibodies were purchased
from Cell Signaling (Beverly, Massachusetts). Mouse monoclonal
anti-p38a antibody was obtained from Zymed (San Francisco,
California). Horseradish peroxydase (HRP)-conjugated goat anti-
rabbit and anti-mouse antibodies were obtained from DAKO
(Glostrup, Denmark).
Cell culture Normal adult skin samples were obtained at plastic
surgery (Dr B. Bienfait, Clinique St. Luc, Namur-Bouge, Belgium)
from informed and consenting donors and keratinocytes were
isolated by the trypsin float technique (Wille et al, 1984). Primary
cultures were propagated in complete keratinocyte growth
medium (KGM-2) (Clonetics, Verviers, Belgium). Proliferating
primary cultures were trypsinized and keratinocytes were plated
into secondary cultures at 6  103 cells per cm2. When the cells
covered approximately 50% of the culture substratum, keratino-
cytes were cultured in autocrine growth medium by excluding
bovine pituitary extract, insulin, transferrin, epinephrine, and EGF
from the KGM-2 medium. Keratinocytes proliferate autonomously
in subconfluent autocrine cultures (Cook et al, 1991), expressing
basal K14 (Poumay and Pittelkow, 1995). Progression of the culture
is characterized by a cell-density-dependent growth arrest,
commitment to differentiation, and expression of differentiation-
specific keratins 1 and 10 (K1, K10) as keratinocytes reach culture
confluence (Poumay and Pittelkow, 1995). During the days past
confluence of the culture, keratinocytes start to express the late
differentiation marker involucrin (Poumay et al, 1999). This simple
culture method provides an easy way to investigate keratinocyte
physiology and its regulation at three defined maturation stades.
The attractivity of this autocrine culture setting is accentuated by
the absence of exogenous factors, which could otherwise
influence keratinocyte physiology in an uncontrollable manner.
Cholesterol depletion Keratinocytes were grown in autocrine
conditions and treatments were performed when the cultures were
subconfluent (covering 70%–80% of the culture substratum) or
confluent, as assessed by morphological observation using phase-
contrast microscopy. Four days after reaching confluence, cultures
were considered to be postconfluent (Poumay et al, 1999).
Cholesterol depletion of cellular membranes was accomplished
by incubating cells in the presence of MbCD (Klein et al, 1995).
MbCD was used at a concentration of 1% (wt/vol), corresponding
to approximately 7.5 mM. This is a classical working concentration
for MbCD and has been previously used for treatment of
keratinocytes (Gniadecki et al, 2002). MbCD-cholesterol inclusion
complexes were prepared according to Klein et al (1995). Where
indicated, cholesterol neosynthesis was inhibited following MbCD
treatment by incubation with 10 mM of the hydroxymethylglutaryl-
coenzyme A reductase inhibitor lovastatin (Kita et al, 1980), of
which a stock solution was prepared in DMSO at 50 mM. Reagents
were dissolved (MbCD) or diluted (lovastatin) in culture medium
immediately before use and treatments were performed with
0.2-mm filtered reagent solutions for indicated times at 371C. When
experiments included lovastatin treatment, control cultures were
incubated with 0.02% (vol/vol) DMSO. For analysis of the effects
of chronic cholesterol depletion on keratinocytes, cultures were
subjected to combined MbCD treatment for up to 1 h and
lovastatin treatment for 17 h. A similar approach was described
by Cooper et al (2003) who used MbCD and statin treatment to
chronically deplete cultured fibroblasts of cholesterol.
All treatments described above were subjected to a cytotoxicity
test (ToxiLight, Cambrex, Verviers, Belgium) used according to the
manufacturer’s instructions. No significant difference in cytotoxicity
was detected between treatments, all of which resulted in 490%
of viable cells. All treatments were also subjected to an apoptosis
assay (In Situ Cell Death Detection Kit, Roche, Basel, Switzerland)
used according to the manufacturer’s instructions. The proportion
of apoptotic cells was o10% in all analyzed samples.
Cholesterol assay Keratinocyte cultures were subjected to
cholesterol depletion, washed with phosphate-buffered saline
(PBS) and lysed with PBS containing 1% (vol/vol) Triton X-100.
Total cholesterol within the lysates was assayed using the
Cholesterol RTU kit (bioMe´rieux, Marcy-l’Etoile, France) according
to the instructions of the manufacturer. The cholesterol concentra-
tion was reported to the protein concentration of the lysates, which
was assayed using the Dc protein assay kit (Bio-Rad, Nazareth
Eke, Belgium).
Filipin staining Filipin has been widely used to localize cellular
cholesterol (Porn and Slotte, 1995). Keratinocytes cultured on
glass slides were subjected to various treatments, washed with
PBS solution, fixed with 4% paraformaldehyde for 30 min, rinsed
with PBS, and incubated with filipin (50 mg per mL) for 30 min at
room temperature. The cells were then washed in PBS, mounted in
Mowiol mounting medium (Molecular Probes, Eugene, Oregon)
and examined by epifluorescent microscopy using a UV filter
(Olympus AX70). Pictures were acquired using a Zeiss AxioCam in
conjunction with Zeiss AxioVision computer software (Carl Zeiss,
Jena, Germany).
Poly(A)RNA isolation and northern blot analysis Poly(A) RNA
was prepared from keratinocyte cultures and analyzed by northern
blotting as described using randomly labelled radioactive probes
(Poumay and Pittelkow, 1995). RNA expression of epidermal
differentiation markers was analyzed by using cDNAs as probes
specific for basal K14 and suprabasal K10 (Roop et al, 1988) and
involucrin (Eckert and Green, 1986). The membrane was also
hybridized with 36B4 cDNA specific for the house-keeping
ribosomal phosphoprotein PO (Laborda, 1991) in order to estimate
the amount of poly(A) RNA loaded onto the gel and transferred to
the membrane. RNA expression was visualized by a Cyclone
apparatus (Packard BioScience Company, Meriden, Connecticut)
using storage phosphor screens.
Western blot analysis of phosphorylated EGFR, HER2, ERK,
and p38 Cellular protein extracts were analyzed by western
blotting as described by Poumay and Pittelkow (1995). Keratino-
cytes were grown in 6 cm Petri dishes (TPP, Trasadingen,
Switzerland), and subjected to the indicated treatments. There-
after, cells were washed with PBS and lysed in twice concentrated
Laemmli sample buffer (Laemmli, 1970). Proteins of interest were
separated by SDS-polyacrylamide gel electrophoresis (PAGE),
blotted onto polyvinylidene difluoride (PVDF) membranes (Amer-
sham, Piscataway, New Jersey) and detected by incubation with
diluted primary rabbit or mouse antibodies. The final detection was
performed with 1:1000 dilutions of HRP-conjugated secondary
anti-rabbit or anti-mouse antibodies and visualized using the POD
Chemiluminescence Blotting Substrate (Roche, Basel, Switzer-
land) on BioMax films (Kodak, Rochester, Minnesota). For the
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detection of other proteins, the membrane was stripped using the
Re-Blot reagent from Chemicon (Temecula, California) and re-
incubated with other antibodies where indicated. To evaluate the
gel loading of equivalent protein levels, tubulin and/or total ERK1/2
(Schmidt et al, 2000) were detected and the membrane was
stained with amidoblack.
Detection of the phosphorylated forms of HER3, p38a, p38b,
and p38d Keratinocyte cultures were grown in 10 cm Petri dishes,
subjected to treatments, then washed and scraped in 1 mL lysis
buffer (PBS containing 1% Triton X-100, protease inhibitors (5 mg
per mL pepstatin A, 1 mg per mL leupeptin, 0.02 mg per mL
aprotinin) and 10 mM sodium orthovanadate as a phosphatase
inhibitor). The lysates were centrifuged in a microfuge for 15 min at
13,000  g at 41C and the resulting supernatants were collected,
pre-absorbed with protein A-agarose (HER3) or protein G-agarose
(p38a, p38b, or p38d) for 1 h and used for immunoprecipitation.
Lysates were incubated with 5 mL of rabbit polyclonal antibodies
against HER3 (or goat polyclonal antibodies against p38a, p38b, or
p38d) for 1 h at 41C on a test tube rotator. Immune complexes were
captured by incubation with protein A-agarose (HER3) or with
protein G-agarose (p38a, p38b, or p38d) for 1 h at 41C. The
agarose beads were then washed five times with PBS containing
0.5% sodium deoxycholate, 1% Triton-X100, and 0.1% SDS. The
immune complexes were released from the beads by boiling
the samples for 5 min in twice concentrated Laemmli sample buf-
fer. The immunoprecipitates were separated by SDS-PAGE and
blotted onto PVDF membranes. Phosphorylated HER3 was
detected by incubation with mouse monoclonal antibodies against
phosphotyrosine (1:500 dilution). Phosphorylated p38a, p38b, or
p38d was detected by incubation with rabbit polyclonal antibodies
against phosphorylated p38 (1:500 dilution). The final detection
was performed as described above. To estimate the amount of
immunoprecipitated HER3, p38a, p38b, or p38d, the membrane
was stripped and re-incubated with antibodies against HER3,
p38a, p38b, or p38d for the detection of the total levels of HER3,
p38a, p38b or p38d.
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